Forte Biosciences, Inc. (FBRX)
- Previous Close
0.6250 - Open
0.6100 - Bid --
- Ask 0.6122 x 100
- Day's Range
0.5703 - 0.6100 - 52 Week Range
0.3800 - 1.0600 - Volume
6,237 - Avg. Volume
26,622 - Market Cap (intraday)
21.949M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8400 - Earnings Date Aug 12, 2024 - Aug 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.25
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
www.fortebiorx.comRecent News: FBRX
Performance Overview: FBRX
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FBRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FBRX
Valuation Measures
Market Cap
22.78M
Enterprise Value
-7.67M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.79
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-60.81%
Return on Equity (ttm)
-104.31%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-32.14M
Diluted EPS (ttm)
-0.8400
Balance Sheet and Cash Flow
Total Cash (mrq)
30.44M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-18.81M